Bicocca Open Archive

Logo unimib boa
CARBONE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.839
EU - Europa 5.504
AS - Asia 2.782
SA - Sud America 217
AF - Africa 42
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.722
IT - Italia 1.463
SG - Singapore 1.186
RU - Federazione Russa 974
DE - Germania 841
CN - Cina 649
SE - Svezia 611
IE - Irlanda 604
HK - Hong Kong 562
GB - Regno Unito 329
BR - Brasile 180
AT - Austria 119
UA - Ucraina 114
NL - Olanda 113
CA - Canada 104
FR - Francia 84
FI - Finlandia 82
TR - Turchia 81
IN - India 73
ID - Indonesia 60
VN - Vietnam 48
DK - Danimarca 45
BE - Belgio 21
JP - Giappone 18
MY - Malesia 18
PT - Portogallo 16
ZA - Sudafrica 15
KR - Corea 13
RO - Romania 12
AR - Argentina 11
PL - Polonia 11
TW - Taiwan 11
CH - Svizzera 9
CZ - Repubblica Ceca 9
IL - Israele 9
EC - Ecuador 8
LT - Lituania 8
PK - Pakistan 7
SK - Slovacchia (Repubblica Slovacca) 7
DZ - Algeria 6
ES - Italia 6
GR - Grecia 6
IR - Iran 6
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
IQ - Iraq 5
MX - Messico 5
AU - Australia 4
BD - Bangladesh 4
GH - Ghana 4
HU - Ungheria 4
MM - Myanmar 4
RS - Serbia 4
TH - Thailandia 4
BO - Bolivia 3
CO - Colombia 3
CR - Costa Rica 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
SA - Arabia Saudita 3
SC - Seychelles 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GE - Georgia 2
JM - Giamaica 2
LU - Lussemburgo 2
MA - Marocco 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
VE - Venezuela 2
ZW - Zimbabwe 2
AL - Albania 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.395
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.274
Singapore 811
Frankfurt am Main 668
Fairfield 634
Dublin 584
Chandler 569
Hong Kong 546
Woodbridge 486
Milan 475
Wilmington 469
Houston 376
Ashburn 348
Santa Clara 306
New York 282
Seattle 254
Dearborn 252
Cambridge 216
Princeton 214
Chicago 169
Jacksonville 147
London 136
Shanghai 125
Vienna 107
Nanjing 104
Lawrence 103
Altamura 101
Rome 80
Beijing 74
San Diego 71
Jakarta 55
Boardman 51
Helsinki 42
Moscow 42
Council Bluffs 36
Nuremberg 36
Florence 35
Los Angeles 35
Toronto 32
Monza 30
Andover 29
Lachine 29
Lissone 27
Nanchang 24
Turin 24
Guangzhou 22
Bari 21
Hangzhou 21
Munich 21
Ottawa 21
Brussels 20
Fremont 20
Pune 20
Changsha 17
Genoa 17
Hebei 17
São Paulo 17
Penang 16
Bologna 15
Norwalk 15
Mountain View 14
Paris 14
Kunming 13
Lisbon 13
Mumbai 13
Tianjin 13
Bergamo 12
Falls Church 12
Jinan 12
Amsterdam 11
Jiaxing 11
Seregno 11
Bedford 10
Rho 10
Shenyang 10
Detroit 9
Dong Ket 9
Edmonton 9
Kocaeli 9
Padova 9
Rio de Janeiro 9
Buffalo 8
Campinas 8
Central 8
Groningen 8
Lappeenranta 8
New Bedfont 8
Ningbo 8
Passignano sul Trasimeno 8
Brno 7
Desio 7
Düsseldorf 7
Istanbul 7
Naples 7
Quito 7
Zhengzhou 7
Bratislava 6
Chengdu 6
Hefei 6
Kiev 6
Kilburn 6
Totale 12.164
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 439
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis 335
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 316
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid 283
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 265
Autoimmune liver disease, autoimmunity and liver transplantation 262
Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation 260
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 260
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 246
Exploring the landscape of steatotic liver disease in the general US population 234
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis 223
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 206
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 204
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 200
Precision medicine in primary biliary cholangitis 199
Female preponderance of primary biliary cholangitis is all about our understanding of its autoimmune nature 198
Risk stratification in primary sclerosing cholangitis 198
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 191
Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland 190
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 189
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 189
Endocrinology and Metabolic Diseases (Including Diabetes) 186
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 184
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 184
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 182
New Therapeutic Targets in Autoimmune Cholangiopathies 177
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 176
The challenges of primary biliary cholangitis: What is new and what needs to be done 176
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 174
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 174
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 173
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 173
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 173
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 171
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis 171
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature 171
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 170
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 161
Autoimmune liver diseases 160
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 159
Leptin attenuates ischemia-reperfusion injury in the rat liver 152
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 148
Reply to: “A spotlight on natural killer cells in primary biliary cholangitis” 147
The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence 147
Genetics and epigenetics of primary biliary cirrhosis 145
Prognostic models in primary biliary cholangitis 144
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 143
Treatment of PBC-A step forward 143
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 141
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 140
Cell and organ bioengineering technology as applied to gastrointestinal diseases 136
How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? 135
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study 134
Hepatitis C virus and nonliver solid organ transplantation 133
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response 132
The "gut microbiota" hypothesis in primary sclerosing cholangitis 131
The immunobiology of female predominance in primary biliary cholangitis 131
Geoepidemiology, Genetic and Environmental Risk Factors for PBC 129
Treatment discontinuation with peg-interferon: What to consider 128
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 128
The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort 127
Late acute liver allograft rejection; A study of its natural history and graft survival in the current era 127
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history 125
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 124
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis 121
Reply to: "Fatigue and liver transplantation in patients with primary biliary cirrhosis" 120
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency 118
The application of artificial intelligence in hepatology: A systematic review 118
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 116
Liver Transplantation in the Clinic - Progress Made During the Last Three Decades 115
Cost of illness of Primary Biliary Cholangitis - a population-based study 115
Calcium channel blockers or angiotensin-converting enzyme inhibitors for de novo hypertension after liver transplant: and the winner is …? 114
An unusual endoscopic finding in a patient with melena: multiple gastric ulcers of regular shape 113
Primary Biliary Cholangitis: advances in management and treatment of the disease 112
Prevention of hepatitis C recurrence after liver transplantation: An update 111
The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study 109
Risk stratification and prognostic modelling in primary biliary cholangitis 109
Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis 108
Toward precision medicine in primary biliary cholangitis 106
Solid organ transplantation: has the promise been kept and the needs met? Solid Organ Transplantation in the Regenerative Medicine Era 106
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 106
Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis 105
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 104
The epigenetics of PBC: The link between genetic susceptibility and environment 102
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 102
Artificial Intelligence and liver: Opportunities and barriers 101
International comparison of liver transplant programmes: differences in indications, donor and recipient selection and outcome between Italy and UK 101
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid 100
Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis 100
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 98
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 97
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All 91
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 91
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 90
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 90
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 89
Individualizing Care: Management Beyond Medical Therapy 89
HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry 89
Artificial intelligence for precision medicine in autoimmune liver disease 86
Management of patients with autoimmune liver disease during COVID-19 pandemic 85
Totale 15.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.409
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020334 0 0 0 0 0 0 0 0 0 178 110 46
2020/20212.605 89 66 379 178 184 261 283 312 237 213 207 196
2021/20221.871 193 187 214 143 141 142 54 105 79 145 170 298
2022/20232.934 333 740 266 252 264 370 126 130 222 76 83 72
2023/20242.687 71 111 108 258 293 580 383 76 156 173 93 385
2024/20254.638 445 717 389 335 500 215 317 288 663 769 0 0
Totale 18.207